Health Condition 1: null- laproscopic surgery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male or female Age between 18 to 55 years at the time of enrollment. 2.Scheduled for elective laparoscopic surgery under general anesthesia 3.ASA physical status I-II 4.Fit for anesthesia 5.Patients who have willingness to participate and provided written informed consent. 6.Ready to comply all schedule of approved protocol.
Exclusion criteria
Exclusion criteria: 1.Uncontrolled hypertension/ diabetes mellitus. 2.Severe hepatic/ respiratory/renal disease. 3.History of congestive cardiac failure, Type II/III heart block. 4.History of allergy to any of the test drugs. 5.Pregnancy or breast feeding female 6.History of opioid / alcohol intake in last 24 hrs. 7.Patients receiving á 2 agonists & Beta Blocker 8.Other medical, psychiatric, or behavioral limitations that in the judgments of the investigators may interfere with study participation or the ability to follow the intervention protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To evaluate effect of clonidine and dexmedetomidine on haemodynamic response in patients undergoing laparoscopic surgeries under sevoflurane anaesthesia 2.To evaluate the recovery characteristics. 3.To find the cost efficacy of clonidine and dexmedetomidine in patients undergoing laparoscopic surgeries under sevoflurane anaesthesia Timepoint: Thease outcome will measures during pre anaesthesia after consent, during anaesthesia and Post anaesthesia till discharge from parameter mentioned in the protocol. | — |
Secondary
| Measure | Time frame |
|---|---|
| Intra operative requirement of NM blocker Duration of Surgery Duration of anesthesia Timepoint: At interventional and post Interventional period | — |
Countries
India